Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Recent advances in smouldering and relapsed or refractory multiple myeloma

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.07.19
Views: 564
Rating:

Dr Jose Sandoval - Moffitt Cancer Center, Tampa, USA

Dr José Sandoval speaks to ecancer at the 2019 ASCO Direct Highlights Symposium in Miami about the latest and potentially practice-changing trials in smouldering and relapsed or refractory multiple myeloma (R/R MM).

He begins by describing the phase III E3A06 trial, which showed that lenalidomide extended progression-free survival in patients with smouldering multiple myeloma versus observation.

Dr Sandoval moves on to R/R MM and discusses the COLOMBA trial, which found that both the subcutaneous and intravenous (IV) administration of daratumumab displayed similar response rates and pharmacokinetics in patients with R/R MM. Conversely, a faster infusion time was achieved with subcutaneous daratumumab compared to IV.

He also describes the phase III ICARIA trial, which showed that the addition of isatuximab to pomalidomide and dexamethasone improved overall response and progression-free survival in patients with R/R MM.

Dr Sandoval concludes by discussing the use of CAR T cells and a bispecific T-cell engager (BiTE) against BCMA, which has shown promising results in patients with R/R MM.

 

Related videos

follow us

Tobacco Dependence e-learning


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation